Patients are not given sufficient information about the novel status of a procedure, possible uncertainties or potential risks when deciding to go ahead with the procedure, research led by the University of Bristol and published in the Annals of Surgery has found.
Study shows not all adrenal carcinoma patients need mitotane after surgery
After the complete tumor resection, not all patients with an adrenocortical carcinoma require the previous standard therapy Mitotane. Professors Martin Fassnacht and Massimo Terzolo show
August 25, 2023